Open access
Open access
Powered by Google Translator Translator

Internal Medicine

RCT: Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir to treat HIV.

23 Jul, 2021 | 10:25h | UTC

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Dolutegravir Confirmed as Effective Second-Line HIV Therapy; Recycling Tenofovir Noninferior to Zidovudine – Medscape (free registration required)

 


Study shows AstraZeneca and Pfizer vaccines are effective against Delta variant, but both doses are needed.

22 Jul, 2021 | 11:16h | UTC

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant – New England Journal of Medicine

Commentaries: Study Finds Pfizer And AstraZeneca Vaccines Effective Against The Delta Variant — As Long As You Get Both Doses – Forbes AND Pfizer’s COVID-19 vaccine works very well against the Delta variant — but only after 2 doses – Insider

Related: [Preprint] 2 doses of Covid vaccines (Pfizer-BioNTech or Oxford-AstraZeneca) highly effective against hospitalization from Delta variant. AND Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. AND Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta.

 

Commentary on Twitter

https://twitter.com/hildabast/status/1417964189566472195

 


Review: The hemostatic and thrombotic complications of liver disease.

23 Jul, 2021 | 10:23h | UTC

The Hemostatic and Thrombotic Complications of Liver Disease – European Journal of Haematology

 


COVID-19 antibodies persist at least nine months after infection – “98.8 percent of people infected in February/March showed detectable levels of antibodies in November”.

22 Jul, 2021 | 11:14h | UTC

News release: COVID-19 antibodies persist at least nine months after infection – Imperial College London

Original study: SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ – Nature Communications

 


RCT: Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19 – safe, but no statistically significant risk reduction in organ dysfunction or death.

22 Jul, 2021 | 11:08h | UTC

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Diabetes & Endocrinology

Commentary: Dapagliflozin in patients with COVID-19: truth or dare – The Lancet Diabetes & Endocrinology

 


Opinion | The benefits of a COVID vaccine far outweigh the small risk of treatable heart inflammation.

22 Jul, 2021 | 10:57h | UTC

The benefits of a COVID vaccine far outweigh the small risk of treatable heart inflammation – The Conversation

 


Analysis finds benefits of COVID-19 vaccination outweigh risks of rare cases of myocarditis.

22 Jul, 2021 | 11:05h | UTC

News release: Study finds benefits of COVID-19 vaccination outweigh risks of rare cases of myocarditis – American Heart Association

Original study: Myocarditis with COVID-19 mRNA Vaccines – Circulation

Commentary: Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns – TCTMD

 

Commentary on Twitter

 


WHO Guidelines for the management of symptomatic sexually transmitted infections.

22 Jul, 2021 | 10:54h | UTC

Guidelines for the management of symptomatic sexually transmitted infections – World Health Organization

News release: Launch WHO guidelines for the management of symptomatic sexually transmitted infection – World Health Organization

 

Commentary on Twitter

 


Review: The routes of administration for acute postoperative pain medication.

22 Jul, 2021 | 10:46h | UTC

The Routes of Administration for Acute Postoperative Pain Medication – Pain and Therapy

 


RCT: Immediate oral refeeding in patients with mild and moderate acute pancreatitis.

22 Jul, 2021 | 10:32h | UTC

Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial) – Annals of Surgery (link to abstract – $ for full-text)

 


Guideline on the management of IgE-mediated food allergies.

22 Jul, 2021 | 10:34h | UTC

Update of the S2k guideline on the management of IgE-mediated food allergies – Allergologie Select

 


A Narrative Review on the Role of Staphylococcus aureus Bacteriuria in S. aureus Bacteremia.

22 Jul, 2021 | 10:37h | UTC

A Narrative Review on the Role of Staphylococcus aureus Bacteriuria in S. aureus Bacteremia – Open Forum Infectious Diseases

 

Commentary on Twitter

 


Expert review | Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy.

21 Jul, 2021 | 10:37h | UTC

Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy – American Journal of Obstetrics & Gynecology

 

Commentary on Twitter

 


Case report: Treatment-induced neuropathy of diabetes related to abrupt glycemic control.

21 Jul, 2021 | 10:33h | UTC

Treatment-induced neuropathy of diabetes related to abrupt glycemic control – Canadian Medical Association Journal

 

Commentaries on Twitter

 


RCT: Central venous access devices (Hickman catheters vs. PICCs vs. PORTs) for the delivery of systemic anticancer therapy – “PORTs are more effective and safer than both Hickman and PICCs”.

21 Jul, 2021 | 10:42h | UTC

Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial – The Lancet (link to abstract – $ for full-text)

News release: Study highlights more effective and safe way to deliver chemotherapy – University of Glasgow

 


Cohort study: Sickle cell disorders and severe COVID-19 outcomes – “Our analysis estimated a 4-fold increased risk for COVID-19–related hospitalization and a 2.6-fold increased risk for COVID-19–related death for sickle cell disease”.

21 Jul, 2021 | 10:44h | UTC

Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study – Annals of Internal Medicine

 


SAGES guidelines for the surgical treatment of gastroesophageal reflux.

21 Jul, 2021 | 10:34h | UTC

SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD) – Surgical Endoscopy

 


EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis.

21 Jul, 2021 | 10:35h | UTC

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – Journal of Hepatology – European Association for the Study of the Liver

 

Commentary on Twitter

 


ICU Survivorship—The relationship of delirium, sedation, dementia, and acquired weakness.

21 Jul, 2021 | 10:32h | UTC

ICU Survivorship—The Relationship of Delirium, Sedation, Dementia, and Acquired Weakness – Critical Care Medicine

 


WHO Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19).

20 Jul, 2021 | 10:29h | UTC

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19) – World Health Organization

Related Guidance: AHA/ASA Guidance: Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia – “No heparin products in any dose should be given.” AND ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine Induced Immune Thrombotic Thrombocytopenia

 


Complications of renal interventions: a pictorial review of CT findings.

21 Jul, 2021 | 10:24h | UTC

Complications of renal interventions: a pictorial review of CT findings – Insights into Imaging

 


Podcast | Common Skin Complaints in Primary Care.

21 Jul, 2021 | 10:22h | UTC

#285 Common Skin Complaints in Primary Care – The Curbsiders

 


International Registry: Ischemic and hemorrhagic stroke among critically ill patients with Covid-19.

20 Jul, 2021 | 10:21h | UTC

Ischemic and Hemorrhagic Stroke Among Critically Ill Patients With Coronavirus Disease 2019: An International Multicenter Coronavirus Disease 2019 Critical Care Consortium Study – Critical Care Medicine

Related: SARS-CoV-2 and Stroke Characteristics – higher rate of large vessel occlusions and stroke in young patients AND Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19 AND Case-control study: COVID-19-associated stroke is associated with worse outcomes and increased mortality AND Pictorial essay: Neurological emergencies associated with COVID-19: stroke and beyond AND Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke AND Risk of Ischemic Stroke in Patients with COVID-19 vs. Patients with Influenza

 


WHO warns that HIV infection increases risk of severe and critical COVID-19.

20 Jul, 2021 | 10:24h | UTC

News release: WHO warns that HIV infection increases risk of severe and critical COVID-19 – World Health Organization

Report: WHO report on clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with SARS-CoV-2 infection

Related: M-A: Epidemiology and outcomes of COVID-19 in HIV-infected individuals – HIV is a significant risk factor for acquiring SARS-CoV-2 infection and is associated with a higher risk of mortality.

 

Commentary on Twitter (thread – click for more)

 


ALA/ATS Response to Philip Morris International’s (PMI) Purchase of British Producer of Respiratory Treatments – “The announcement that PMI wants to acquire an inhaled medicine company is the latest reprehensible choice from a company that has profited from addicting users to its deadly products”.

20 Jul, 2021 | 10:12h | UTC

American Lung Association and the American Thoracic Society Response to Philip Morris International’s Purchase of British Producer of Respiratory Treatments – American Thoracic Society

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.